Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
US-Listed Public Company Profile built from SEC and market records · June 2026

Natera, Inc. (NTRA)

$404.90 +0.24% NASDAQ: NTRA · 15-min delayed
  • AUSTIN, Texas
  • Public · NASDAQ: NTRA
  • 6,140 employees
$37.5BMarket cap
$2.3BRevenue · FY2025
-$208.2MNet income
6,140Employees
NTRANASDAQ
2015IPO

About Natera, Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$2.3B
Net income
-$208.2M
Total assets
$2.4B
Market cap
$37.5B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: NTRA
$404.90 +0.24%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$160.21 $425.64

52-week range

Market cap
$37.5B
Shares outstanding
92.7M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Jul 2, 2015

Natera, Inc. (NTRA) Stock Price

  • Reported a net loss of $208.2M in FY2025.
  • Trading 5% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Natera, Inc..

Write a review
Newsroom

News about Natera, Inc.

News & sentiment via Polygon.io

FAQ

Natera, Inc.: frequently asked questions

Is Natera, Inc. an American company?

Yes — Natera, Inc. is an American company. Natera, Inc. is incorporated in Delaware, United States and headquartered in Austin, Texas. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Natera, Inc. incorporated?

Natera, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Natera, Inc.?

Natera, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Natera, Inc. traded on a US stock exchange?

Yes — Natera, Inc. trades under the ticker NTRA on the NASDAQ.

Where is Natera, Inc. headquartered?

Natera, Inc. is headquartered in Austin, Texas, United States.

Is Natera, Inc. publicly traded?

Yes — Natera, Inc. is a publicly traded company. Its stock trades under the ticker symbol NTRA on the NASDAQ.

What does Natera, Inc. do?

Natera, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →